# OnCo record paper-jiang-lancet-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-jiang-lancet-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-jiang-lancet-oncol" ;
  schema:name "Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial"@en ;
  schema:description "Paper cited by one treatment page, indexed on Europe PMC as PubMed record 31036468 and published in The Lancet Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-jiang-lancet-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(19)30164-0>, <https://pubmed.ncbi.nlm.nih.gov/31036468/>, <https://europepmc.org/article/MED/31036468> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(19)30164-0> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Jiang Z, Li W, Hu X, et al." ;
  onco:related <https://onco.cc/drugs/tucidinostat/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .